Search

everythinglearnresearchcommunity

for

Search:↓

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Understanding and treating alopecia areata improves patient care.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Early detection and treatment of primary biliary cirrhosis and related autoimmune diseases improve outcomes.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Large doses of glucocorticoids are not suitable for general use in treating severe alopecia areata due to inconsistent results and risks.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Vitiligo causes white skin patches and is linked to autoimmune issues.

Stress hormones and autoimmune reactions can cause hair loss.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Thyroid function affects skin health, with a complex interaction between the two.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.